Valuation
MDMGMother and Child (MD Medical Group)
StockMoscow ExchangeRussiaHealth care
+0.1% today · +0.8% over a year
7/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 79% of the instruments we score
Quality, Stability: among the best of its peers; priced higher than most peers. Dividend yield 6.60%.
Ratios vs sector
Medians of Health care companies worldwide (too few in the region).
| Metric | MDMG | Sector median | vs median |
|---|---|---|---|
| P/E | — | 28.0 · n=177 | — |
| P/B | — | 3.8 · n=349 | — |
| P/S | — | 4.3 · n=338 | — |
| EV/EBIT | — | 24.6 · n=168 | — |
| Free-cash-flow yield | — | 1.5% · n=330 | — |
| Dividend yield | 6.60% | 0.00% · n=470 | — |
| Return on equity | — | −1.8% · n=362 | — |
| Return on invested capital | — | 2.6% · n=323 | — |
| Gross margin | — | 64.2% · n=244 | — |
| Net debt / EBITDA | — | 1.30 · n=171 | — |
Value factor: 23 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 48.1 | 32.9 | — | 1.5% | 0.6% | 7/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 39.8 | 7.9 | — | 3.2% | 2.0% | 8/10 |
| ABBVAbbVie | 49.1 | — | 27.1 | 3.7% | 3.0% | 6/10 |
| UNHUnitedHealth | 22.8 | 3.5 | 17.3 | 6.3% | 2.2% | 10/10 |
| MRKMerck | 112.5 | 8.5 | — | 4.5% | 2.4% | 9/10 |
| NOVNNovartis AG | 21.9 | 6.6 | 18.3 | 5.7% | 2.8% | 10/10 |
| NVSNovartis AG | 21.7 | 6.6 | 18.2 | 5.8% | 2.5% | 10/10 |
| AZNAstraZeneca plc | 28.0 | 5.9 | 22.6 | 4.1% | 1.7% | 7/10 |
| AZNAstraZeneca PLC | 27.9 | 5.9 | 22.5 | 4.1% | 1.2% | 6/10 |
| TMOThermo Fisher Scientific | 36.6 | 4.7 | 34.7 | 2.9% | 0.3% | 9/10 |
ratios computed by AI-Stock Invest from public filings and end-of-day prices
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.